The most crucial limitation of our analyze was The shortcoming to test a PD-one/PD-L1 inhibitor together with S and S+R due to unavailability of the rat cross reactive antibody. Even so, we did display PD-L1 upregulation on- or publish- procedure with S and S+R for this reason substantially addressing this limitation.I employed it being a TGF-beta